Способ получения соли олигогексаметиленгуанидина высокой степени чистоты

Objectives. Given that microorganisms can become resistant to certain groups of drugs and considering also their ability to form biofilms, the development of new drugs that are active against adapted microflora is required. This study focused on the development of a new method for the synthesis of a promising compound, the branched hydrosuccinate oligohexamethylene guanidine (OHMGsucc), with high purity that meets the standards of the 14th edition State Pharmacopeia of the Russian Federation (SPRF). Previously proposed methods have managed to isolate this product, which, however, complies with the requirements of the outdated SPRF. Therefore, the main aim of this study was to update the regulatory framework for the indicated OHMG salt for its further use in the pharmaceutical industry according to modern standards.Methods. To control the residual impurities of hexamethylenediamine (HMDA) and guanidine hydrochloride (GHC), high-performance liquid chromatography (HPLC) was applied using a Thermo Scientific Dionex UltiMate 3000 chromatograph, and the chromatographic signals of the test solution with those of a standard sample solution obtained by a previously published conventional method were compared.Results. The HPLC experimental data indicated a significant difference in the quantitative content of HMDA and GHC observed for the new and older preparation method of the branched OHMGsucc, suggesting that the method disclosed in this article can be used to obtain highly pure OHMGsucc.Conclusions. The specified compound was standardized with the parameter “related impurities” according to the current (14th) edition of the SPRF. The effectiveness and reproducibility of the proposed method was experimentally confirmed. In addition, a process diagram for the preparation of the indicated OHMG salt was prepared.Цели. На фоне приобретения микроорганизмами резистентности к определенным группам лекарственных средств, а также способностей образовывать биопленки, требуются новые препараты, активные против адаптированной микрофлоры. Cтатья посвящена изысканию способа получения перспективного соединения – разветвленного гидросукцината олигогексаметиленгуанидина с высокой степенью чистоты, соответствующей нормам Государственной Фармакопеи 14 издания. Так как предложенные ранее методы позволяли получить продукт, удовлетворяющий требованиям устаревшей Государственной Фармакопеи, то основной целью являлась актуализация нормативной базы в отношении указанной соли олигогексаметиленгуанидина для ее дальнейшего применения в фармацевтической отрасли согласно современным стандартам.Методы. Для контроля примесных соединений – гексаметилендиамина и гуанидина гидрохлорида применяли высокоэффективную жидкостную хроматографию, которую проводили на хроматографе Thermo Scientific Dionex UltiMate 3000 методом внешнего стандарта.Результаты. На основании экспериментальных данных, полученных с помощью высокоэффективной жидкостной хроматографии, отображена разница в количественном содержании остаточных примесей в составе субстанции разветвленного гидросукцината олигогексаметиленгуанидина, полученной двумя разными способами. Отмечено, что способ, предложенный авторами настоящей статьи, позволяет снизить их содержание по сравнению с конвенциональным методом.Выводы. Согласно представленным данным проведена стандартизация указанного соединения по параметру «Родственные примеси» в соответствии с актуальным на данный момент изданием Государственной Фармакопеи. Вследствие того, что эффективность предложенного метода экспериментально подтвердилась, на заключительном этапе работы была составлена технологическая схема получения указанной соли олигогексаметиленгуанидина

Разработка и валидация метода контроля мономерной примеси гидрохлорида гуанидина в фармацевтической субстанции «разветвленный гидрохлорид олигогексаметиленгуанидина»

Some existing methodologies for quantitative estimation of guanidine hydrochloride during the analysis of various samples were described. Their shortcomings impeding the implementation of the control of the monomer in the pharmaceutical substance were identified. A method for quantitative determination of guanidine hydrochloride in pharmaceutical substance “branched oligo(hexamethyleneguanidine) hydrochloride” by high performance liquid chromatography was developed. The method was validated to standardize the substance by the parameter “impurity compounds”.Описаны существующие методы определения гидрохлорида гуанидина при анализе различных образцов, указаны их недостатки, препятствующие осуществлению контроля мономера в фармацевтической субстанции. Разработана методика количественного определения гидро-хлорида гуанидина в фармацевтической субстанции «разветвленный гидрохлорид олигогекса-метиленгуанидина» с помощью высокоэффективной жидкостной хроматографии, проведена ее валидация с целью стандартизации субстанции по параметру «примесные соединения»

DOSAGE FORMS OF NONSTEROIDAL ANTI-INFLAMMATORY PHARMACEUTICAL SUBSTANCE FOR CONTROLLED RELEASE

This review is about nonsteroidal anti-inflammatory drugs and different approaches to development of pharmaceutical forms for controlled nonsteroidal anti-inflammatory drug release. Natural and synthetic biocompatible polymers used as drug carriers were considered. Different methods used for production of polymeric microparticles and formulations of nonsteroidal anti-inflammatory agents based on them were discussed. Characterization of microparticles with encapsulated nonsteroidal anti-inflammatory agents was given

An effective method for preparation of high purity oligohexamethylene guanidine salts

Objectives. Given that microorganisms can become resistant to certain groups of drugs and considering also their ability to form biofilms, the development of new drugs that are active against adapted microflora is required. This study focused on the development of a new method for the synthesis of a promising compound, the branched hydrosuccinate oligohexamethylene guanidine (OHMGsucc), with high purity that meets the standards of the 14th edition State Pharmacopeia of the Russian Federation (SPRF). Previously proposed methods have managed to isolate this product, which, however, complies with the requirements of the outdated SPRF. Therefore, the main aim of this study was to update the regulatory framework for the indicated OHMG salt for its further use in the pharmaceutical industry according to modern standards.Methods. To control the residual impurities of hexamethylenediamine (HMDA) and guanidine hydrochloride (GHC), high-performance liquid chromatography (HPLC) was applied using a Thermo Scientific Dionex UltiMate 3000 chromatograph, and the chromatographic signals of the test solution with those of a standard sample solution obtained by a previously published conventional method were compared.Results. The HPLC experimental data indicated a significant difference in the quantitative content of HMDA and GHC observed for the new and older preparation method of the branched OHMGsucc, suggesting that the method disclosed in this article can be used to obtain highly pure OHMGsucc.Conclusions. The specified compound was standardized with the parameter “related impurities” according to the current (14th) edition of the SPRF. The effectiveness and reproducibility of the proposed method was experimentally confirmed. In addition, a process diagram for the preparation of the indicated OHMG salt was prepared

Development and validation of the method of control monomer impurities guanidine hydrochloride in pharmaceutical substance “branched hydrochloride oligo(hexamethyleneguanidine)”

Some existing methodologies for quantitative estimation of guanidine hydrochloride during the analysis of various samples were described. Their shortcomings impeding the implementation of the control of the monomer in the pharmaceutical substance were identified. A method for quantitative determination of guanidine hydrochloride in pharmaceutical substance “branched oligo(hexamethyleneguanidine) hydrochloride” by high performance liquid chromatography was developed. The method was validated to standardize the substance by the parameter “impurity compounds”

Oligohexamethylene Guanidine Derivative as a Means to Prevent Biological Fouling of a Polymer-Based Composite Optical Oxygen Sensor

The use of biocidal agents is a common practice for protection against biofouling in biomass-rich environments. In this paper, oligohexamethyleneguanidine (OHMG) polymer, known for its biocidal properties, was further modified with para-aminosalicylic acid (PAS) to enhance its properties against microorganisms coated with a lipid membrane. The structure of the product was confirmed by 1H NMR, 13C NMR, and FTIR spectroscopy. The values of the minimum inhibitory concentration (MIC) against Mycobacterium smegmatis ATCC 607 and Pseudomonas chlororaphis 449 were found to be 1.40 and 1.05 μg/mL, respectively. The synthesized substance was used as an additive to the polymer matrix of the composite optical oxygen sensor material. A series of samples with different contents of OHMG-PAS was prepared using a co-dissolution method implying the fabrication of a coating from a solution containing both polymers. It turned out that the mutual influence of the components significantly affects the distribution of the indicator in the matrix, surface morphology, and contact angle. The optimal polymer content turned out to be wt.3%, at which point the water contact angle reaches almost 122°, and the fouling rate decreases by almost five times, which is confirmed by both the respiratory MTT assay and confocal microscopy with staining. This opens up prospects for creating stable and biofouling-resistant sensor elements for use in air tanks or seawater